Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

Published:2021-02-04 Issue:9 Volume:27 Page:2648-2662
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Wang Xian,Veeraraghavan Jamunarani,Liu Chia-Chia,Cao Xixi,Qin Lanfang,Kim Jin-Ah,Tan Ying,Loo Suet Kee,Hu Yiheng,Lin Ling,Lee Sanghoon,Shea Martin J.,Mitchell Tamika,Li Shunqiang,Ellis Matthew J.^ORCID,Hilsenbeck Susan G.^ORCID,Schiff Rachel^ORCID,Wang Xiao-Song

Funder

NIH

Susan G. Komen

Congressionally Directed Medical Research Programs

CDMRP

Breast Cancer Research Foundation

Stand Up To CancerAmerican Association for Cancer ResearchAmerican Association for Cancer Research

Hillman Foundation

NCINHGRINHGRI

Cancer Prevention and Research Institute of Texas

NCI

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nemo‐like kinase blocks myeloid differentiation by targeting tumor suppressor C/EBPα in AML;The FEBS Journal;2024-08-07

2. VX-702 Ameliorates the Severity of Sepsis-Associated Acute Kidney Injury by Downregulating Inflammatory Factors in Macrophages;Journal of Inflammation Research;2024-06

3. Identification of diagnostic markers related to inflammatory response and cellular senescence in endometriosis using machine learning and in vitro experiment;Inflammation Research;2024-05-04

4. Chimeric Peptide‐Engineered Self‐Delivery Nanomedicine for Photodynamic‐Triggered Breast Cancer Immunotherapy by Macrophage Polarization;Small;2023-12-14

5. Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents;International Journal of Molecular Sciences;2023-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3